Ocuphire Pharma

Ocuphire Pharma is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders.

Industries

Pharmaceutical

Headquarters

Farmington Hills, United States

Stage

Post IPO Equity

Employees

11-50

Links

Org chart

Richard Rodgers

Interim CEO

Collapse

Charlie Hoffmann

SVP of Corporate Development and Operations

Amy Rabourn

SVP of Finance

Drey Coleman

VP, Clinical Operations

Ronil Patel

SVP, Operations & Business Development

Daniela C. Oniciu

Global Head of R&D, Chemistry & Product Development

Chris Ernst

Global Head, QA & Manufacturing

Mitchell Brigell

Head of Clinical Development & Strategy

Bindu Manne

Head of Market Development & Commercialization

Laura Gambino

Director of Project Management

Teams

View all

+14

Board of Directors

17 members

Leadership Team

8 members

CEO and Executive Team

0 members

Discover similar companies

Walgreens Boots Alliance

Deerfield, United States

Eli Lilly

Indianapolis, United States · Series E

Omnicell

Mountain View, United States

Alnylam Pharmaceuticals

Cambridge, United States · Post IPO Debt

Bristol-Myers Squibb

Lawrence Township, United States

AbbVie

North Chicago, United States · Series B

Prescient Healthcare Group

Jersey City, United States · Private Equity

Viatris

Pittsburgh, United States

Nano Hearing Aids

Phoenix, United States

Catalent

Franklin Township, United States · Venture

Rgenta Therapeutics

Woburn, United States · Series A

Cerevel Therapeutics

Boston, United States · Post IPO Debt

The Org
helps you hire
great candidates

It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.